Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin and Metronidazole for SIBO
NCT02458781Phase 4Unknown
- Sponsor
- Brooke Army Medical Center
- Start
- Jan 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ciprofloxacin, metronidazole in small intestinal bacterial overgrowth (SIBO), sponsored by Brooke Army Medical Center. Status: unknown.
02
Drugs
ciprofloxacinmetronidazole
03
Conditions
small intestinal bacterial overgrowth (SIBO)
Beyond the preview
Go deeper on NCT02458781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458781.